In our patients, the decrease of NF-κB expression in the skin, coupled with normalization of S100A9 serum levels, may suggest that AHSCT affects epithelial cells involved with SSc pathogenesis, such as the keratinocytes. Here, NFKB1 is linked to systemic sclerosis.